Automatic Oxygen Administration After Major Abdominal and Thoracic Surgery

NCT ID: NCT02546830

Last Updated: 2019-01-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-01-31

Study Completion Date

2018-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to assess the use feasibility of the FreeO2 system so as to deliver automatically oxygen in the post anesthesia care unit in a patient population admitted for major abdominal and thoracic surgery.

The investigators' hypothesis is that FreeO2 system will provide a better control of the oxygen saturation and reduce postoperative hypoxaemia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Major Thoracic and Abdominal Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FreeO2 v2.2 active

Automatic Oxygen Administration

Group Type EXPERIMENTAL

FreeO2 v2.2 active

Intervention Type DEVICE

* Automatic adjustment of oxygen through the "Free O2" device.
* "FreeO2" device in mode medical data collecting(SpO2,EtCO2...).

FreeO2 v2.2 with manual oxygenation

Manual Oxygen Administration

Group Type ACTIVE_COMPARATOR

FreeO2 v2.2 with manual oxygenation

Intervention Type DEVICE

* Manual adjustment of oxygen without the assistance of the "FreeO2" device.
* Only "FreeO2" device in mode medical data collecting(SpO2,EtCO2...).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FreeO2 v2.2 active

* Automatic adjustment of oxygen through the "Free O2" device.
* "FreeO2" device in mode medical data collecting(SpO2,EtCO2...).

Intervention Type DEVICE

FreeO2 v2.2 with manual oxygenation

* Manual adjustment of oxygen without the assistance of the "FreeO2" device.
* Only "FreeO2" device in mode medical data collecting(SpO2,EtCO2...).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Preoperative anesthetic visit for major thoracic or abdominal surgery ( ARISCAT risk score ≥ 26) with general anesthesia
* Patient consent

Randomization Criteria:

* Admission in post-anesthesia care unit after major thoracic or abdominal surgery
* Randomization and device establishment within a time less than one hour after the endotracheal intubation
* Availability of the prototype FreeO2
* Absence of criteria of gravity justifying immediately a different technique of ventilatory support:

* Disturbance of consciousness with a Glasgow Coma Score ≤ 12
* Serious ventricular rhythm disorders
* Hemodynamic instability (SBP \<80mmHg or recourse to vasopressors)
* Cardiac or respiratory arrest
* pH \< 7.35 and PaCO2 \> 55 mm Hg
* Necessity of an oxygen flow less than 15 L / min to maintain a SpO2 higher than 92%.
* Absence of necessity of a urgent surgery
* Oxygen saturation measured by Spo2 sensor

Exclusion Criteria

* BMI ≥ 35 kg/m2
* Obstructive sleep Apnea (with or without Mechanical therapy)
* Emergency Surgery for life-threatening
* Age \<18 years
* Pregnant women, lactating
* perturbed or non-cooperative patient
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Brest

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Erwan L'HER

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Brest

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Laval - Québéc

Québéc, , Canada

Site Status

Brest, University Hospital

Brest, , France

Site Status

CHU Clermont-Ferrand

Clermont-Ferrand, , France

Site Status

CHU Montpellier

Montpellier, , France

Site Status

CHU Poitiers

Poitiers, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada France

References

Explore related publications, articles, or registry entries linked to this study.

L'Her E, Jaber S, Verzilli D, Jacob C, Huiban B, Futier E, Kerforne T, Pateau V, Bouchard PA, Consigny M, Lellouche F. Automated closed-loop versus standard manual oxygen administration after major abdominal or thoracic surgery: an international multicentre randomised controlled study. Eur Respir J. 2021 Jan 5;57(1):2000182. doi: 10.1183/13993003.00182-2020. Print 2021 Jan.

Reference Type DERIVED
PMID: 32855218 (View on PubMed)

L'her E, Jaber S, Verzilli D, Jacob C, Huiban B, Futier E, Kerforne T, Pateau V, Bouchard PA, Gouillou M, Nowak E, Lellouche F. Automated oxygen administration versus conventional oxygen therapy after major abdominal or thoracic surgery: study protocol for an international multicentre randomised controlled study. BMJ Open. 2019 Jan 17;9(1):e023833. doi: 10.1136/bmjopen-2018-023833.

Reference Type DERIVED
PMID: 30782716 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHRU de Brest

Identifier Type: REGISTRY

Identifier Source: secondary_id

RB14-060

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Management of Moderately Hypoxemic Thoracic Trauma
NCT03997630 ACTIVE_NOT_RECRUITING NA